Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 37Prostatic Neoplasms 19Multiple Myeloma 17Neoplasm Metastasis 14Osteoporosis 8Neuroblastoma 6Pain 5Osteosarcoma 5Neoplasms, Plasma Cell 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 4Carcinoma, Renal Cell 4Sarcoma, Ewing 3Bone Diseases, Metabolic 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteonecrosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Giant Cell Tumor of Bone 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Adenocarcinoma 2

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Zoledronic Acid × Clear all
NCT00206388 2013-08-02

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Baylor College of Medicine

Phase 1 Completed
21 enrolled
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡